Psychoneuroendocrinology

Jump to: navigation, search

WikiDoc Resources for Psychoneuroendocrinology

Articles

Most recent articles on Psychoneuroendocrinology

Most cited articles on Psychoneuroendocrinology

Review articles on Psychoneuroendocrinology

Articles on Psychoneuroendocrinology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Psychoneuroendocrinology

Images of Psychoneuroendocrinology

Photos of Psychoneuroendocrinology

Podcasts & MP3s on Psychoneuroendocrinology

Videos on Psychoneuroendocrinology

Evidence Based Medicine

Cochrane Collaboration on Psychoneuroendocrinology

Bandolier on Psychoneuroendocrinology

TRIP on Psychoneuroendocrinology

Clinical Trials

Ongoing Trials on Psychoneuroendocrinology at Clinical Trials.gov

Trial results on Psychoneuroendocrinology

Clinical Trials on Psychoneuroendocrinology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Psychoneuroendocrinology

NICE Guidance on Psychoneuroendocrinology

NHS PRODIGY Guidance

FDA on Psychoneuroendocrinology

CDC on Psychoneuroendocrinology

Books

Books on Psychoneuroendocrinology

News

Psychoneuroendocrinology in the news

Be alerted to news on Psychoneuroendocrinology

News trends on Psychoneuroendocrinology

Commentary

Blogs on Psychoneuroendocrinology

Definitions

Definitions of Psychoneuroendocrinology

Patient Resources / Community

Patient resources on Psychoneuroendocrinology

Discussion groups on Psychoneuroendocrinology

Patient Handouts on Psychoneuroendocrinology

Directions to Hospitals Treating Psychoneuroendocrinology

Risk calculators and risk factors for Psychoneuroendocrinology

Healthcare Provider Resources

Symptoms of Psychoneuroendocrinology

Causes & Risk Factors for Psychoneuroendocrinology

Diagnostic studies for Psychoneuroendocrinology

Treatment of Psychoneuroendocrinology

Continuing Medical Education (CME)

CME Programs on Psychoneuroendocrinology

International

Psychoneuroendocrinology en Espanol

Psychoneuroendocrinology en Francais

Business

Psychoneuroendocrinology in the Marketplace

Patents on Psychoneuroendocrinology

Experimental / Informatics

List of terms related to Psychoneuroendocrinology

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch. } Psychoneuroendocrinology is the clinical study of hormone fluctuations and their relationship to human behavior. It may be viewed from the perspective of psychiatry, where in certain mood disorders, there are associated neuroendocrine or hormonal changes. It may also be viewed from the perspective of endocrinology, where certain endocrine disorders can be associated with psychiatric illness. It is the blend of psychiatry and endocrinology.

Disorders

Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder

Premenstrual dysphoric disorder (PMDD) is a more severe form of premenstrual syndrome affecting 3-8% of women in their reproductive years. PMDD mood disturbances are more severe than those of PMS. The most common symptom is irritability. Many women also report depressed mood, anxiety, or mood swings. These symptoms emerge one to two weeks preceding menses and resolve completely with the onset of menses. By definition, this mood disturbance results in marked social or occupational impairment, with its most prominent effects in interpersonal functioning. PMDD is a psychiatric diagnosis and is considered to be one of the affective disorders, classified in the DSM-IV-TR as "depressive disorder not otherwise specified." PMDD can be distinguished from other affective disorders primarily by the cyclical nature of the mood disturbance. Unlike other affective disorders, mood symptoms are only present for a specific period of time, during the luteal phase of the menstrual cycle. Additionally, these mood symptoms do not occur in the absence of a menstrual cycle, as during reproductive events such as pregnancy or menopause. [1]

Postpartum Depression (PPD)

Postpartum psychiatric illness is typically divided into three categories: (1) postpartum blues (2) postpartum depression and (3) postpartum psychosis. It may be useful to conceptualize these disorders as existing along a continuum, where postpartum blues is the mildest and postpartum psychosis the most severe form of postpartum psychiatric illness.

50 to 85% of women experience postpartum blues during the first few weeks after delivery. Given how common this type of mood disturbance is, it may be more accurate to consider the blues as a normal experience following childbirth rather than a psychiatric illness. Rather than feelings of sadness, women with the blues more commonly report mood lability, tearfulness, anxiety or irritability. These symptoms typically peak on the fourth or fifth day after delivery and may last for a few hours or a few days, remitting spontaneously within two weeks of delivery.

Postpartum depression is clinically indistinguishable from depression occurring at other times during a woman's life. Especially with milder cases, it may be difficult to detect postpartum depression because many of the symptoms used to diagnose depression (i.e., sleep and appetite disturbance, fatigue) also occur in postpartum women in the absence of depression. The Edinburgh Postnatal Depression Scale[2] is a 10-item questionnaire that may be used to identify women who have PPD. On this scale, a score of 12 or greater or an affirmative answer on question 10 (presence of suicidal thoughts) raise concern and indicate a need for more thorough evaluation.

Postpartum psychosis is the most severe form of postpartum psychiatric illness. It is a rare event that occurs in approximately 1 to 2 per 1000 women after childbirth. Its presentation is often dramatic, with onset of symptoms as early as the first 48 to 72 hours after delivery. The majority of women with puerperal psychosis develop symptoms within the first two postpartum weeks. [3]

External Links

References

Cost Effectiveness of Psychoneuroendocrinology

| group5 = Clinical Trials Involving Psychoneuroendocrinology | list5 = Ongoing Trials on Psychoneuroendocrinology at Clinical Trials.govTrial results on PsychoneuroendocrinologyClinical Trials on Psychoneuroendocrinology at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Psychoneuroendocrinology | list6 = US National Guidelines Clearinghouse on PsychoneuroendocrinologyNICE Guidance on PsychoneuroendocrinologyNHS PRODIGY GuidanceFDA on PsychoneuroendocrinologyCDC on Psychoneuroendocrinology


| group7 = Textbook Information on Psychoneuroendocrinology | list7 = Books and Textbook Information on Psychoneuroendocrinology


| group8 = Pharmacology Resources on Psychoneuroendocrinology | list8 = AND (Dose)}} Dosing of PsychoneuroendocrinologyAND (drug interactions)}} Drug interactions with PsychoneuroendocrinologyAND (side effects)}} Side effects of PsychoneuroendocrinologyAND (Allergy)}} Allergic reactions to PsychoneuroendocrinologyAND (overdose)}} Overdose information on PsychoneuroendocrinologyAND (carcinogenicity)}} Carcinogenicity information on PsychoneuroendocrinologyAND (pregnancy)}} Psychoneuroendocrinology in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Psychoneuroendocrinology


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Psychoneuroendocrinology | list9 = AND (pharmacogenomics)}} Genetics of PsychoneuroendocrinologyAND (pharmacogenomics)}} Pharmacogenomics of PsychoneuroendocrinologyAND (proteomics)}} Proteomics of Psychoneuroendocrinology


| group10 = Newstories on Psychoneuroendocrinology | list10 = Psychoneuroendocrinology in the newsBe alerted to news on PsychoneuroendocrinologyNews trends on Psychoneuroendocrinology


| group11 = Commentary on Psychoneuroendocrinology | list11 = Blogs on Psychoneuroendocrinology

| group12 = Patient Resources on Psychoneuroendocrinology | list12 = Patient resources on PsychoneuroendocrinologyDiscussion groups on PsychoneuroendocrinologyPatient Handouts on PsychoneuroendocrinologyDirections to Hospitals Treating PsychoneuroendocrinologyRisk calculators and risk factors for Psychoneuroendocrinology


| group13 = Healthcare Provider Resources on Psychoneuroendocrinology | list13 = Symptoms of PsychoneuroendocrinologyCauses & Risk Factors for PsychoneuroendocrinologyDiagnostic studies for PsychoneuroendocrinologyTreatment of Psychoneuroendocrinology

| group14 = Continuing Medical Education (CME) Programs on Psychoneuroendocrinology | list14 = CME Programs on Psychoneuroendocrinology

| group15 = International Resources on Psychoneuroendocrinology | list15 = Psychoneuroendocrinology en EspanolPsychoneuroendocrinology en Francais

| group16 = Business Resources on Psychoneuroendocrinology | list16 = Psychoneuroendocrinology in the MarketplacePatents on Psychoneuroendocrinology

| group17 = Informatics Resources on Psychoneuroendocrinology | list17 = List of terms related to Psychoneuroendocrinology


}}



Linked-in.jpg